Results 171 to 180 of about 15,072 (244)

UNI-494 treatment improves measures of renal dysfunction and cardiac pathology in male rats receiving L-NAME and angiotensin II. [PDF]

Physiol Rep
Ho FJM, Siow CJR, Aljaibeji H, Ding M, Mitchell RN, Medicherla S, Reddy G, Gupta S, Williams GH, Romero JR.   +9 more
europepmc   +1 more source

Hyperreflective choroidal foci may predict pachychoroid macular atrophy development in central serous chorioretinopathy. [PDF]

Eye (Lond)
Pignataro MG, Termite AC, Borrelli E, Boscia G, Reibaldi M, Micelli Ferrari L, Ribezzi G, Carra A, Dore S, Evangelista F, Alessio G, Boscia F, Viggiano P.   +12 more
europepmc   +1 more source

Kidney function trajectories before and after hospitalization for heart failure with reduced ejection fraction. [PDF]

Eur Heart J
Kobayashi M, Bayes-Genis A, Duarte K, McMurray JJV, Ferreira JP, Pocock SJ, Van Veldhuisen DJ, Lupón J, Pitt B, Zannad F, Girerd N.   +10 more
europepmc   +1 more source

PO-FP-067 MINERALOCORTICOID RECEPTOR ANTAGONIST THERAPY IN PATIENTS WITH HEART FAILURE AND SUSTAINED MONOMORPHIC VENTRICULAR TACHYCARDIA: A COMPARATIVE ANALYSIS OF SPIRONOLACTONE VS. EPLERENONE [PDF]

Ferenc Komlósi, I Szakál, Patrik Tóth, Bence Arnóth, G Y Bohus, Péter Vámosi, Nándor Szegedi, Zoltán Salló, István Osztheimer, Péter Perge, Gábor Orbán, Béla Merkely, László Gellér, Klaudia Vivien Nagy   +13 more
openalex   +1 more source

Efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a meta-analysis of randomized controlled trials. [PDF]

BMC Cardiovasc Disord
Wu J, Pei Y, Wu J, Huang Y.
europepmc   +1 more source

THE CHOICE OF COMPONENTS AND THE IMPACT OF SURFACTANTS AND CO-SURFACTANTS ON EPLERENONE NANOEMULSION SYNTHESIS FOR GEL-BASED TRANSDERMAL APPLICATION

Ms. Harshada Pramod Gaikwad, Rajendra Marathe, Inayat Bashir Pathan   +2 more
openalex   +2 more sources

Recent advances in mineralocorticoid receptor antagonists for heart failure with preserved ejection fraction: focus on finerenone in the era of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists. [PDF]

Front Pharmacol
Wang TY, Zhang L, Wang HY, Jiang FF.
europepmc   +1 more source

Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysis [PDF]

, 2016
Chao Zheng, Chun-Ying Li, Hai-Min Yin, Jin-Jue Zheng, Liang-Xue Wang, Meng-Di Fan, Meng-Die Chen, Ning-Yu Cai, Si-Si Dong, Su-Ping Gu, Xin-He Zhou   +10 more
core   +1 more source

Development and validation of RP-HPLC method for estimation of eplerenone in spiked human plasma

, 2012
Paraag Gide, Sandeep Sonawane, A.S. Chitnis   +2 more
openalex   +1 more source

Correction: Adverse effects of finerenone in patients with heart failure: a systematic review and meta-analysis. [PDF]

Front Cardiovasc Med
Yu W, Luo F, Rao J, Lei G, Wu Q, Shen W, Yang P, Li P.   +7 more
europepmc   +1 more source